MktsMarkets

MacroGenics, Inc.
NASDAQ: MGNXKey statistics
MGNX News
Stories mentioning MGNX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 20,775 | 41,228 | 72,839 | 22,241 | 13,192 | 19,353 | 110,708 | 10,797 |
| Cost of Goods Sold | 0.00 | 0.00 | 0.00 | 0.00 | 233.00 | 168.00 | 176.00 | |
| Gross Profit | 41,228 | 72,839 | 22,241 | 13,192 | 19,120 | 110,540 | 10,621 | |
| Operating Expenses | ||||||||
| Research & Development | 34,974 | 33,974 | 32,709 | 40,791 | 39,698 | 38,890 | 40,543 | 51,732 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (33,439) | (12,095) | 18,636 | (36,758) | (42,624) | (52,838) | 54,191 | (58,181) |
| Interest Income | ||||||||
| Interest Expense | 4,889 | 3,342 | 802.00 | 91.00 | (24.00) | 0.00 | 6.00 | |
| Other Expense | ||||||||
| Pretax Income | 16,822 | (36,146) | 56,309 | (55,664) | ||||
| Tax Provision | 0.00 | 105.00 | 0.00 | 0.00 | ||||
| Net Income (Loss) | (36,774) | (14,155) | 16,822 | (36,251) | (41,036) | (15,421) | 56,309 | (55,664) |
| Earnings Per Share (Basic) | (0.58) | (0.22) | 0.27 | (0.57) | (0.65) | (0.25) | 0.90 | (0.89) |
| Earnings Per Share (Diluted) | (0.58) | (0.22) | 0.27 | (0.57) | (0.65) | (0.25) | 0.90 | (0.89) |
| Weighted Average Shares Outstanding (Basic) | 63,450 | 63,155 | 63,233 | 63,136 | 62,965 | 62,621 | 62,744 | 62,664 |
| Weighted Average Shares Outstanding (Diluted) | 63,450 | 63,155 | 63,284 | 63,136 | 62,965 | 62,621 | 62,866 | 62,664 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MGNX
MacroGenics, Inc. (NASDAQ: MGNX) is a stock listed on the Nasdaq Stock Market under the ticker symbol MGNX. It last traded at $2.33 (Nov 2, 2026, 4:00 PM ET), down 2.9% on the day. That gives MacroGenics a market capitalisation of $152.9M.
Over the past 52 weeks MGNX has traded between $1.29 and $5.08.
Revenue for the quarter ended Mar 31, 2026 was $20.8M; a net loss of $36.8M. Revenue was up 57.5% from $13.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $20.8M | -$36.8M | -177.0% |
| Dec 31, 2025 | $41.2M | -$14.2M | -34.3% |
| Sep 30, 2025 | $72.8M | $16.8M | 23.1% |
| Jun 30, 2025 | $22.2M | -$36.3M | -163.0% |
From MacroGenics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…